NewcelX Ltd. (NCEL)
$3.19-$0.23 (-6.73%) Today
Latest NCEL Insider Trades
Olivier Samuel - DirectorOpen-market purchase$225K
Olivier Samuel - Director
Michel Revel - OfficerMichel Revel - OfficerNewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.
No Form 4 activity for NCEL in the last 90 days.
2 Form 4 filings on record, the earliest from Apr 29, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Olivier Samuel - Director | Open-market purchase | Common Shares, par value CHF 0.05 per share | 81,818 | $2.75 | $225K | |
| Olivier Samuel - Director | Open-market purchase | Warrant (right to buy) | 114,545 | - | - | |
| Michel Revel - Officer | Open-market purchase | Common Shares, par value CHF 0.05 per share | 54,545 | $2.75 | $150K | |
| Michel Revel - Officer | Open-market purchase | Warrant (right to buy) | 76,363 | - | - |
NewcelX Ltd. (NCEL) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-29. The full record for NCEL runs to 2 Form 4 filings, the earliest from 2026-04-29. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of NCEL were filed in the last 90 days. 4 purchases are on record for this company.
No insider sales of NCEL were filed in the last 90 days.
This page tracks NCEL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NCEL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$NCINeo-Concept International Group Holdings Ltd
$NCLANuclea Energy Inc.
$NCNANuCana plc
$NCOSouthern Cross Acquisition I Corp.
$NCPLNetcapital Inc.
$NCRANOCERA, INC.
$NCTIntercont (Cayman) Ltd
$NCVVirtus Convertible & Income Fund
$NCZVirtus Convertible & Income Fund II
$NDPTORTOISE ENERGY INDEPENDENCE FUND, INC.Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.